Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Valeant CEO Will Cite 'Mistakes' in Price-Hiking Strategy

April 27, 2016 9:49 am | by Matthew Perrone, AP Health Writer | News | Comments

J. Michael Pearson will issue the unusual mea culpa on Capitol Hill for the business strategy that made Valeant an industry powerhouse but also triggered a backlash against the Canadian drugmaker.

TOPICS:

MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment

April 27, 2016 9:28 am | by University of Cincinnati | News | Comments

Cancer researchers have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.

TOPICS:

The New Focus on IL-12 in Oncology Research

April 26, 2016 3:23 pm | by Dr. Premal Thaker M.D., Washington University School of Medicine; Dr. Charles Leath III, M.D., University of Alabama School of Medicine | Articles | Comments

In recent years, researchers have made considerable headway in efforts to improve both the pharmacokinetics and safety of therapies based on rIL-12 based on the use of more advanced delivery mechanisms.

TOPICS:
Advertisement

South Korean Pharmaceutical Market to Experience Slow Four-Year Growth

April 26, 2016 2:00 pm | by Adam Dion, MSc, Senior Industry Analyst, GlobalData | Articles | Comments

Many novel drugs are set to lose their patents by 2020, meaning South Korea’s generics market is expected to increase significantly.

TOPICS:

Could Marijuana Help Treat Painkiller and Heroin Addiction?

April 26, 2016 1:00 pm | by Michael Casey, Associated Press | News | Comments

The growing number of patients who claim marijuana helped them drop their painkiller habit has intrigued lawmakers and emboldened advocates.

TOPICS:

Early-Morning Flu Shots are More Potent, Suggests Study

April 26, 2016 12:28 pm | by Ryan Bushey, Digital Editor | Articles | Comments

Vaccinations for three different influenza strains were given to an approximate 276 adults, over the age of 65.

TOPICS:

BMS' Opdivo Gains Breakthrough Therapy Designation

April 26, 2016 12:02 pm | News | Comments

The label is for previously treated recurrent or metastatic squamous cell carcinoma of the head and neck.

TOPICS:

Scientists Provide New Insight into Gene Regulation

April 26, 2016 12:00 pm | by University of Leicester | News | Comments

The function of the NuRD complex is to control the amount of protein made by the cell.

TOPICS:
Advertisement

SPARK Project to Examine DNA of 50,000 Autistic Kids, Looking for Solutions

April 26, 2016 10:13 am | by Seth Augenstein, Digital Reporter | News | Comments

A genomics research project hopes to collect and cross-reference the DNA of 50,000 people to better understand the autism spectrum.

TOPICS:

New R&D Pact Seeks Cure for Aging-Related Diseases

April 26, 2016 10:06 am | by Ryan Bushey, Digital Editor | Articles | Comments

Google’s Calico, an institution with a mysterious mission to “cure death” could have competition from a new collaboration between Ascentage Pharma and Unity Biotechnology.

TOPICS:

Study Proves Anti-Smoking Pills Don't Raise Suicide Risk

April 26, 2016 10:06 am | by Ryan Bushey, Digital Editor | Articles | Comments

Over the course of 12 weeks, patients were administered either Chantix or Zyban, a nicotine patch, or a placebo followed by an additional 12 weeks of follow-up.

TOPICS:

Solving Structures of GLP-1, Glucagon Receptors for Metabolic Disease

April 26, 2016 9:40 am | News | Comments

Both receptors play important roles in the management of blood glucose levels and are considered to be important targets for drugs to treat metabolic diseases, such as diabetes.

TOPICS:

HIV PrEP Too Pricey to Use in People Who Inject Drugs

April 26, 2016 9:32 am | by American College of Physicians | News | Comments

Even at lower drug prices, HIV PrEP for injection drug users may not be an efficient use of HIV prevention resources. 

TOPICS:

Widely-Used Class of Chemo Drugs May Not Lead to Cognitive Decline

April 26, 2016 9:15 am | by UCLA | News | Comments

UCLA researchers have found that a commonly used chemotherapy drug does not appear to cause cognitive decline following treatment in women with breast cancer.

TOPICS:

Fighting Against Counterfeit Medicine

April 26, 2016 8:37 am | by Michigan State University | News | Comments

Around the world, especially in developing nations, counterfeit medicines are a real problem.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading